Exploring how TP53 affects lung cell changes related to pulmonary fibrosis
Determining the role of TP53 regulation in alveolar epithelial transitional cell state, and the contribution of alveolar epithelial transitional cell state to pulmonary fibrosis
This study is looking at how a protein called TP53 helps lung cells change when they get injured, which could help us understand and find new treatments for pulmonary fibrosis, a serious lung condition that affects breathing.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11141548 on NIH RePORTER |
What this research studies
This research investigates the role of the TP53 protein in regulating the transition of alveolar epithelial cells, which are crucial for lung function. By examining how these cells change in response to injury and contribute to pulmonary fibrosis, the study aims to uncover the underlying mechanisms of this severe lung disease. The approach includes analyzing single-cell data from human lungs affected by fibrosis to identify key molecular pathways. Patients may benefit from insights that could lead to new treatment strategies for pulmonary fibrosis.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pulmonary fibrosis or those experiencing unexplained lung injury.
Not a fit: Patients with other respiratory conditions that do not involve pulmonary fibrosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic targets for treating pulmonary fibrosis, potentially improving patient outcomes.
How similar studies have performed: Previous research has shown promising results in understanding cellular transitions in lung diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Morowitz, Jeremy — Duke University
- Study coordinator: Morowitz, Jeremy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.